Cancer researchers are increasingly exploring whether they can eliminate or scale back treatments to spare patients from tough side effects—and costs—without jeopardizing survival.
Cancer researchers are increasingly exploring whether they can eliminate or scale back treatments to spare patients from tough side effects—and costs—without jeopardizing survival.